Linked Life Data

15071125

Source:http://linkedlifedata.com/resource/pubmed/id/15071125

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
15
pubmed:dateCreated
2004-4-8
pubmed:abstractText
Decreased high-density lipoprotein (HDL) cholesterol levels constitute a major risk factor for coronary heart disease; however, there are no therapies that substantially raise HDL cholesterol levels. Inhibition of cholesteryl ester transfer protein (CETP) has been proposed as a strategy to raise HDL cholesterol levels.
pubmed:grant
pubmed:commentsCorrections
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/Anticholesteremic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Apolipoprotein A-I, http://linkedlifedata.com/resource/pubmed/chemical/Apolipoprotein A-II, http://linkedlifedata.com/resource/pubmed/chemical/CETP protein, human, http://linkedlifedata.com/resource/pubmed/chemical/Carrier Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, HDL, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol, LDL, http://linkedlifedata.com/resource/pubmed/chemical/Cholesterol Ester Transfer Proteins, http://linkedlifedata.com/resource/pubmed/chemical/Glycoproteins, http://linkedlifedata.com/resource/pubmed/chemical/Heptanoic Acids, http://linkedlifedata.com/resource/pubmed/chemical/Hydroxymethylglutaryl-CoA..., http://linkedlifedata.com/resource/pubmed/chemical/Pyrroles, http://linkedlifedata.com/resource/pubmed/chemical/Quinolines, http://linkedlifedata.com/resource/pubmed/chemical/Triglycerides, http://linkedlifedata.com/resource/pubmed/chemical/atorvastatin, http://linkedlifedata.com/resource/pubmed/chemical/torcetrapib
pubmed:status
MEDLINE
pubmed:month
Apr
pubmed:issn
1533-4406
pubmed:author
pubmed:copyrightInfo
Copyright 2004 Massachusetts Medical Society
pubmed:issnType
Electronic
pubmed:day
8
pubmed:volume
350
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1505-15
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:15071125-Adult, pubmed-meshheading:15071125-Aged, pubmed-meshheading:15071125-Anticholesteremic Agents, pubmed-meshheading:15071125-Apolipoprotein A-I, pubmed-meshheading:15071125-Apolipoprotein A-II, pubmed-meshheading:15071125-Carrier Proteins, pubmed-meshheading:15071125-Cholesterol, HDL, pubmed-meshheading:15071125-Cholesterol, LDL, pubmed-meshheading:15071125-Cholesterol Ester Transfer Proteins, pubmed-meshheading:15071125-Drug Therapy, Combination, pubmed-meshheading:15071125-Female, pubmed-meshheading:15071125-Glycoproteins, pubmed-meshheading:15071125-Heptanoic Acids, pubmed-meshheading:15071125-Humans, pubmed-meshheading:15071125-Hydroxymethylglutaryl-CoA Reductase Inhibitors, pubmed-meshheading:15071125-Male, pubmed-meshheading:15071125-Middle Aged, pubmed-meshheading:15071125-Pyrroles, pubmed-meshheading:15071125-Quinolines, pubmed-meshheading:15071125-Single-Blind Method, pubmed-meshheading:15071125-Triglycerides
pubmed:year
2004
pubmed:articleTitle
Effects of an inhibitor of cholesteryl ester transfer protein on HDL cholesterol.
pubmed:affiliation
Lipid Research Laboratory, Division of Endocrinology, Metabolism, Diabetes, and Molecular Medicine, New England Medical Center and Tufts University School of Medicine, Boston, MA 02111, USA. margaret.brousseau@tufts.edu
pubmed:publicationType
Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Controlled Clinical Trial, Research Support, Non-U.S. Gov't